S&P 500
(0.07%) 5 472.88 points
Dow Jones
(0.09%) 39 146 points
Nasdaq
(0.37%) 17 784 points
Oil
(-0.01%) $80.82
Gas
(-3.66%) $2.66
Gold
(-0.76%) $2 313.00
Silver
(0.25%) $28.94
Platinum
(3.64%) $1 022.30
USD/EUR
(0.28%) $0.936
USD/NOK
(0.70%) $10.68
USD/GBP
(0.45%) $0.792
USD/RUB
(-0.28%) $87.25

实时更新: Oncorus, Inc. [ONCR]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间30 Dec 2023 @ 03:55

-3.08% $ 0.126

Live Chart Being Loaded With Signals

Commentary (30 Dec 2023 @ 03:55):

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers...

Stats
今日成交量 135 947
平均成交量 108 675
市值 3.29M
EPS $-1.280 ( Q1 | 2023-05-22 )
Last Dividend $0.139 ( 2023-12-26 )
Next Dividend $0 ( N/A )
P/E -0.0362
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00400 (3.17%)
AADI -3.23%
ABCL 1.65%
ABCM 0.04%
ABEO -2.61%
ABIO -3.08%
ABOS 0.70%
ABSI 1.87%
ABUS -1.80%
ABVX -1.50%
ACAD -0.56%
ACER -17.95%
ACET -5.25%
ACGN 1.29%
ACHL 1.59%
ACHV -0.65%
ACIU -0.75%
ACLX 0.80%
ACRV -2.31%
ACST -2.90%
ACXP 1.38%
ADAG 4.64%
ADAP -4.05%
ADGI 0.87%
ADIL 1.75%
ADMA -2.18%
ADPT 0.12%
ADTX -2.38%
ADVM -3.62%
ADXN -1.60%
AEON -4.66%
AEZS -2.49%
AFMD -2.01%
AGEN -1.82%
AGIO -2.42%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 0.54%
AKRO -3.23%
AKTX 1.45%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC 0.92%
ALGS -0.74%
ALKS 0.25%
ALLK -9.46%
ALLO -6.19%
ALLR -0.53%
ALNA 3.16%
ALNY 2.41%
ALPN 0.02%
ALPX 0.00%
ALRN -1.33%
ALT -9.31%
ALVR 2.60%
ALXN 0.00%
ALXO -13.24%
ALZN 5.27%
AMRN -1.68%
AMTI -3.13%
ANAB 1.45%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX 0.22%
ANPC -3.15%
APGE -0.08%
APGN 8.48%
APGNW 30.65%
APLM -2.22%
APLS 0.25%
APLT -3.04%
APM 0.36%
APOP 0.38%
APRE 0.60%
APTO 5.98%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -4.79%
ARDS -14.23%
ARDX 0.00%
ARGX -0.90%
ARNA 0.00%
ARPO -0.90%
ARQT -0.42%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.23%
ARWR -0.65%
ASLN -3.83%
ASMB -5.81%
ASND -1.74%
ATAI -2.22%
ATHA 5.02%
ATHE 0.56%
ATHX -33.50%
ATNF 4.29%
ATOS 2.44%
ATRA -2.06%
ATXI -2.78%
ATXS -0.55%
AUPH -0.99%
AURA 2.79%
AUTL -1.72%
AVBP -1.89%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -3.10%
AVTX -1.25%
AVXL -4.06%
AXLA 0.00%
AXSM -1.08%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.78%
BCAB 5.57%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 4.36%
BCRX 0.25%
BCTX 8.90%
BCTXW -16.32%
BCYC 0.80%
BDRX -4.62%
BDTX -1.28%
BEAM 0.93%
BFRA -2.91%
BGNE -2.78%
BIOR -6.17%
BIVI 3.41%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.78%
BLU 0.03%
BLUE 0.58%
BMEA -11.05%
BMRN 0.08%
BNOX 6.22%
BNTC -0.42%
BNTX -1.66%
BOLD -12.19%
BOLT -0.65%
BPMC -1.14%
BPTH 0.00%
BPTS -13.47%
BRNS 0.00%
BRTX -3.52%
BTAI 24.72%
BTTX 50.67%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 4.24%
CABA 1.66%
CADL -2.12%
CALA 0.00%
CALC -1.77%
CALT -1.59%
CAPR -1.72%
CARA -0.06%
CARM 13.48%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.89%
CCCC -6.26%
CCXI 0.00%
CDAK 0.00%
CDIO -2.18%
CDIOW 24.00%
CDMO -2.96%
CDMOP 0.04%
CDT -4.84%
CDTTW -39.60%
CDTX -1.31%
CDXC 0.82%
CDXS 7.40%
CELC -4.21%
CELU -1.00%
CELUW 11.80%
CERC -1.68%
CERE -1.42%
CERO -3.90%
CEROW -21.56%
CFRX -27.95%
CGEM -3.13%
CGEN -3.31%
CGON -1.62%
CGTX -4.55%
CHMA -6.00%
CHRS 1.90%
CINC 0.00%
CING -2.73%
CINGW 34.95%
CKPT -3.83%
CLBS -16.75%
CLDX -1.30%
CLGN 0.34%
CLLS -4.15%
CLNN 0.00%
CLNNW 0.00%
CLRB 6.30%
CLSD -4.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 0.00%
CMPI 0.00%
CMPX -1.42%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.48%
CNCE 0.00%
CNSP -35.92%
CNST 0.00%
CNTA -0.28%
CNTB 0.00%
CNTX -7.31%
COCP -2.00%
COEPW 32.45%
COGT -3.49%
CORT 2.80%
COYA -1.46%
CPRX -1.06%
CRBP -3.20%
CRBU -6.53%
CRDF -1.11%
CRGX -0.07%
CRIS -1.72%
CRNX -6.03%
CRSP 0.70%
CRTX 2.63%
CRVO -5.75%
CRVS 1.69%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -4.13%
CTNM -2.21%
CTXR 2.82%
CUE 6.57%
CVAC -5.10%
CVKD -2.85%
CWBR 2.80%
CYAD -12.96%
CYCC 9.09%
CYCCP 5.49%
CYCN -0.24%
CYT -2.27%
CYTK -2.02%
CYTO -1.82%
DARE 4.02%
DAWN -1.19%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 29.65%
DNLI -1.38%
DNTH -10.07%
DOMH 2.43%
DRMA -4.04%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.45%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.72%
DTIL 1.99%
DYAI 12.26%
EARS -1.77%
EDIT -2.52%
EDSA 3.19%
EFTR 5.11%
EFTRW -51.85%
EIGR -9.21%
ELAB -2.84%
ELDN 8.99%
ELEV -6.22%
ELOX -5.38%
ELTX -4.26%
ELVN -4.10%
ELYM 2.23%
ENGN -1.73%
ENGNW 0.00%
ENLV 2.90%
ENOB 1.79%
ENSC 3.23%
ENTA 0.08%
ENTO -2.42%
ENTX 1.60%
ENVB 1.58%
EPIX -2.36%
EPRX -1.15%
EPZM 0.00%
EQ 0.34%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.72%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -3.31%
ETON 1.83%
ETTX 0.00%
EVAX -2.14%
EVGN 4.76%
EVLO 0.00%
EWTX -0.29%
EXAI -1.13%
EXEL -0.04%
EYEG -0.69%
EYEN 0.60%
EYPT 0.36%
FATE -10.08%
FBIO 1.06%
FBIOP -0.37%
FBLG -15.40%
FBRX -0.02%
FDMT -3.32%
FENC -1.29%
FGEN -7.30%
FHTX 6.87%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -1.67%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.40%
FULC -3.47%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.25%
GANX -2.31%
GBIO -2.83%
GBT 0.01%
GDTC 0.50%
GERN -4.54%
GHRS -2.30%
GLMD -4.94%
GLPG -2.11%
GLSI 1.43%
GLTO -2.16%
GLUE -3.17%
GLYC -10.09%
GMAB -0.58%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.14%
GNLX -0.22%
GNPX 1.49%
GNTA 3.94%
GOSS -10.93%
GOVX 2.27%
GOVXW -49.04%
GPCR -7.53%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.48%
GRTX 5.14%
GTHX 0.91%
GUTS -4.39%
GXGXW 41.67%
GYRE -8.82%
HALO -1.43%
HARP 0.09%
HCWB -3.75%
HEPA -4.09%
HGEN -84.62%
HILS 5.66%
HLVX 0.15%
HOOK 2.33%
HOTH -3.51%
HOWL -1.71%
HRMY 1.83%
HRTX 4.10%
HSTO 0.00%
HUMA 0.51%
HUMAW -0.01%
IBRX -4.13%
ICCC 0.22%
ICPT 0.21%
ICU 19.10%
ICUCW 20.46%
ICVX -0.91%
IDRA -23.04%
IDYA -1.80%
IFRX -1.85%
IGMS -0.51%
IKNA 1.19%
IKT -0.35%
IMAB 2.33%
IMCR -2.89%
IMGN 0.02%
IMGO 0.00%
IMMP 3.97%
IMMX -7.76%
IMNM 0.52%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -0.58%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -4.59%
INAB -0.01%
INBX 0.63%
INCY -1.33%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM 1.53%
INMB 1.82%
INO -1.31%
INSM -1.45%
INTS -2.75%
INVA 0.55%
INZY 0.80%
IOBT -10.63%
IONS 0.97%
IOVA -3.49%
IPA -0.49%
IPHA 5.58%
IPSC -2.54%
IRON -1.89%
ISEE 0.38%
ITOS -1.71%
ITRM 1.67%
IVA 6.96%
IVVD -2.89%
JAGX 1.18%
JANX -3.93%
JAZZ -0.57%
JNCE 0.00%
JSPR -6.17%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -5.80%
KDNY 0.22%
KMPH -0.34%
KNSA -1.85%
KNTE -0.38%
KOD -6.72%
KPRX 0.96%
KPTI -5.05%
KRBP -10.00%
KRON 0.58%
KROS -1.07%
KRRO -8.11%
KRTX 0.03%
KRYS -0.41%
KTRA 9.57%
KTTA -6.79%
KTTAW 0.92%
KURA -0.24%
KYMR -2.95%
KYTX -4.40%
KZIA 2.65%
KZR -1.04%
LABP 0.57%
LBPH -1.74%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.75%
LENZ -5.05%
LEXX -0.77%
LEXXW -14.63%
LGND -0.50%
LGNDV 0.00%
LGVN -7.61%
LIAN -8.28%
LIFE 2.70%
LIPO -3.87%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.39%
LPCN -1.86%
LPTX -2.75%
LQDA -0.08%
LRMR -1.92%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX -1.03%
LXEO -4.08%
LXRX -2.06%
LYEL -36.60%
LYRA 1.20%
MACK 0.10%
MBIO -9.47%
MBRX -1.72%
MCRB 2.74%
MDGL -1.14%
MDNA -13.16%
MDWD -0.14%
MDXG -2.50%
MEIP 1.40%
MESO -1.26%
MGNX -2.10%
MGTA -7.74%
MGTX -3.61%
MGX -4.02%
MIRM -1.03%
MIRO 0.59%
MIST 1.15%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX 0.25%
MLYS -7.37%
MNKD 0.38%
MNMD 0.14%
MNOV 2.11%
MNPR -8.52%
MOLN 1.79%
MOR 1.20%
MORF -3.22%
MREO -2.71%
MRKR 2.57%
MRNA -5.97%
MRNS -4.04%
MRSN -2.15%
MRTX -0.17%
MRUS 0.09%
MRVI -1.15%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.08%
MYMD 5.75%
NAMS 3.32%
NAMSW -0.21%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 0.73%
NERV -0.63%
NEXI 1.84%
NGM -1.28%
NGNE -1.41%
NKGN 10.08%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.89%
NLSP 5.88%
NLSPW 26.67%
NMRA -2.86%
NMTR -42.97%
NOVN -24.84%
NRBO 7.28%
NRIX -2.31%
NRSN -5.12%
NRSNW 0.00%
NRXP -3.72%
NRXPW 18.33%
NRXS 4.82%
NTBL 4.01%
NTEC -12.45%
NTHI 0.00%
NTLA -6.75%
NTRBW -31.07%
NUVL -1.78%
NVAX -2.11%
NVCT 3.55%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 1.32%
OABIW -10.06%
OBIO -3.07%
OBSV 0.00%
OCEA 0.00%
OCGN 2.12%
OCS -1.00%
OCUL -0.15%
OCUP 1.84%
ODT -4.27%
OKYO 1.51%
OLMA -5.29%
OMER -1.16%
OMGA 5.63%
ONCO 4.18%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 1.38%
ONTX -0.47%
ONVO 0.47%
OPNT 0.00%
OPT 3.09%
ORGS 0.96%
ORIC -3.41%
ORMP 17.83%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.43%
OVID 0.80%
OYST 0.00%
PALI 1.30%
PASG -1.30%
PBLA -7.50%
PBM -3.48%
PBYI 1.18%
PCSA 0.00%
PCVX -0.39%
PDSB -3.16%
PEPG 1.37%
PGEN -2.69%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.32%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.47%
PLUR 7.39%
PMN 0.72%
PMVP -0.60%
PNT 0.16%
PPBT -5.92%
PRAX 4.05%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 0.00%
PRQR -0.66%
PRTA -2.50%
PRTC 0.49%
PRTG 7.02%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.46%
PSTX -1.16%
PTCT -0.45%
PTE -0.82%
PTGX -0.87%
PTIXW -48.41%
PULM 2.60%
PXMD 4.76%
PYPD 0.07%
PYXS 0.33%
QLGN -3.00%
QNCX 5.70%
QNRX -1.14%
QSI -11.97%
QSIAW -3.13%
QTTB -3.45%
QURE -0.78%
RAIN -1.63%
RANI 6.42%
RAPT -1.30%
RARE 1.54%
RCKT -8.60%
REGN 0.23%
RENB -3.11%
REPL -2.38%
RETA 0.02%
REUN -0.89%
REVB -2.79%
REVBU 3.46%
REVBW 5.00%
RGLS -6.78%
RGNX -5.88%
RIGL -3.29%
RLAY -3.86%
RLMD 0.35%
RLYB -1.34%
RNA 0.49%
RNAC -2.94%
RNAZ -1.90%
RNXT 0.89%
ROIV -2.08%
ROIVW 4.56%
RPHM -0.93%
RPRX 0.26%
RPTX 0.15%
RUBY 2.70%
RVLP -32.05%
RVMD -1.13%
RVMDW -30.00%
RVNC 0.21%
RVPH -1.98%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.89%
RYTM -5.60%
RYZB 0.02%
RZLT 3.09%
SABS -1.37%
SABSW -11.81%
SAGE 1.28%
SANA -3.87%
SAVA -0.16%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -0.06%
SCPH 4.77%
SCPS 0.00%
SEEL -4.08%
SEER 0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -0.83%
SGMT -2.42%
SGTX -2.56%
SIOX 22.63%
SLDB -8.97%
SLGL 4.12%
SLN -4.57%
SLNO -4.57%
SLRX 5.27%
SLS -1.71%
SMMT -1.62%
SNDX 1.23%
SNGX -4.91%
SNPX -4.39%
SONN 0.00%
SPPI -0.49%
SPRB 0.63%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -0.98%
SRRA 0.00%
SRRK -2.11%
SRZN -2.45%
STAB 0.00%
STOK -5.52%
STRO -3.34%
STSA 0.00%
STTK -1.69%
SURF -0.93%
SVRA -8.16%
SWTX -0.27%
SYBX -1.29%
SYRS -1.55%
TALS -0.73%
TARA -7.62%
TARS 0.39%
TBPH 0.54%
TCBP 2.48%
TCDA 0.00%
TCON 2.46%
TCRR 0.00%
TCRT 0.08%
TCRX -1.45%
TECH -0.11%
TENX 1.91%
TERN -8.41%
TFFP -5.33%
TGTX -4.38%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -4.60%
TNGX -3.67%
TNXP -6.40%
TNYA -4.73%
TPST 5.35%
TRDA -4.06%
TRVI 2.30%
TRVN 1.60%
TSHA -22.87%
TSVT -3.46%
TTNP -7.66%
TVTX 1.51%
TYRA -8.54%
UBX -2.84%
UNCY -4.50%
URGN -1.15%
UTHR 0.56%
VACC 11.36%
VALN -4.07%
VAXX 114.20%
VBIV 0.33%
VBLT -8.77%
VCEL 0.96%
VCNX 10.35%
VCYT -1.59%
VERA -4.20%
VERU 0.97%
VERV -2.96%
VIGL 4.84%
VINC 2.28%
VIR 0.98%
VIRI -1.73%
VIRX 3.15%
VKTX -1.57%
VLON -13.04%
VNDA -3.42%
VOR -1.61%
VRCA 0.00%
VRDN -4.55%
VRNA -0.53%
VRPX 0.38%
VRTX 0.28%
VSTM -1.02%
VTGN -1.81%
VTVT -2.97%
VTYX -1.46%
VXRT -5.10%
VYGR -0.26%
VYNE -4.62%
VYNT 7.78%
WINT 2.18%
WVE -6.39%
XBIO 1.03%
XBIT -0.53%
XCUR 3.55%
XENE -1.51%
XERS 2.62%
XFOR 4.17%
XLO 3.88%
XLRN 0.00%
XNCR 0.36%
XOMA -3.23%
XOMAO -0.16%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.67%
ZNTL -2.14%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-06-06 Shea Brian J. Sell 0 Common Stock
2023-06-06 Shea Brian J. Sell 15 000 Employee Stock Option (right to buy)
2023-06-06 Shea Brian J. Sell 3 744 Employee Stock Option (right to buy)
2023-06-06 Shea Brian J. Sell 14 700 Employee Stock Option (right to buy)
2023-06-06 Shea Brian J. Sell 19 100 Employee Stock Option (right to buy)
INSIDER POWER
-62.73
Last 97 transactions
Buy: 2 441 000 | Sell: 694 654

音量 相关性

長: 0.41 (neutral)
短: 0.27 (neutral)
Signal:(89.911) Neutral

Oncorus, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Oncorus, Inc. 相关性 - 货币/商品

The country flag -0.41
( neutral )
The country flag -0.06
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.04
( neutral )

Oncorus, Inc. 财务报表

Annual 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $-3.02
FY 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $-3.02
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-2.56
FY 2020
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-9.35

Financial Reports:

No articles found.

Oncorus, Inc. Dividends

(Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.139
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Oncorus, Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.139 2023-12-26
Last Dividend $0.139 2023-12-26
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.139 --
Avg. Dividend % Per Year 16.67% --
Score 4.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-06-26)
$0.279 Estimate 2.50 %
Dividend Stability
0.20 Very Poor
Dividend Score
4.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2023 $0.139 50.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
26 Dec 2023 $0.139 30 Nov -0001 30 Nov -0001 30 Nov -0001

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Diamond 2024-09-16 Monthly 14 15.03% 9.60
DMLP Dividend Diamond 2024-04-26 Quarterly 22 10.71% 9.35
OXSQ Dividend Diamond 2024-09-16 Monthly 21 12.73% 9.02
ARLP Dividend Royal 2024-05-07 Quarterly 26 9.67% 8.87
PNNT Dividend Royal 2024-06-14 Monthly 18 9.49% 8.82
MFIC Dividend Royal 2024-06-11 Quarterly 21 10.89% 8.79
SPOK Dividend Royal 2024-05-23 Quarterly 20 8.73% 8.72
PSEC Dividend Royal 2024-06-25 Monthly 21 9.03% 8.65
SBLK Dividend Royal 2024-06-06 Quarterly 17 13.10% 8.63
GBDC Dividend Royal 2024-11-29 Bi-Monthly 15 8.53% 8.62

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-0.6811.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-1.3061.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.5000.8007.506.00[1 - 3]
quickRatioTTM1.4460.8006.204.96[0.8 - 2.5]
cashRatioTTM0.6821.5007.3210.00[0.2 - 2]
debtRatioTTM0.631-1.50010.00-10.00[0 - 0.6]
interestCoverageTTM52.091.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.6262.00-0.542-1.084[0 - 30]
freeCashFlowPerShareTTM-2.142.00-1.071-2.14[0 - 20]
debtEquityRatioTTM2.23-1.5001.099-1.649[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.6131.000-4.52-4.52[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.437

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.04401.000-0.1050[1 - 100]
returnOnEquityTTM-1.3062.50-10.00-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-2.142.00-0.714-2.14[0 - 30]
dividendYielPercentageTTM110.581.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM-1.6262.00-0.542-1.084[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.0002021.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.012

Oncorus, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Oncorus, Inc.

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。

Total Execution Time: 3.9966280460358 seconds
Number of API calls: 3
Number of DB calls: 9